NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Quantal Bioscience

Quantal Bioscience

Private
Castle HillHealthcare & Life Scienceshttps://www.quantalbioscience.com/

Last Round

Series B

Feb 9, 2026

Total Funding Raised

$130M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Quantal Bioscience is a biotechnology company that provides research and development services in applied microbiology and microbiomics across the health, medical, food, agricultural, and environmental sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Quality Management, Environmental Monitoring

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

applied microbiologymicrobiomicslaboratory servicescontract researchmicrobiome analysiscontract research organizationCROfood safety testingshelf-life testingchallenge testingmicrobial identificationmycologyfood spoilagefermentation scienceprocess validationcrop healthenvironmental microbiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Quantal Bioscience Comparables

Compare Quantal Bioscience with similar companies based on industry and business-model similarity.

Quantal Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eurofins Scientific SE
75%
Biomcare
73%
Metagen Australia
66%

Quantal Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 9, 2026
Series AAug 26, 2022

Quantal Bioscience Investors

Notable investors and investment history

Quantal Bioscience investors
InvestorRounds
Creacion VenturesSeries A, Series B
OrbiMedSeries B, Series A
Sanofi VenturesSeries B
Lilly Asia VenturesSeries B
HongShan Capital Group (HSG)Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 245% MoM, reaching 1K.

  • Feb 9, 2026

    $85M round led by Sanofi Ventures and Lilly Asia Ventures.

Quantal Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Quantal Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Quantal Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersCastle Hill
Employee Range7
Year FoundedN/A
Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.